More about

Continuous Glucose Monitor

News
August 26, 2024
3 min read
Save

Personal CGM use in hospitals feasible, preferred by nurses and patients

Personal CGM use in hospitals feasible, preferred by nurses and patients

A change to hospital policy allowing patients to use their own continuous glucose monitors instead of finger-stick blood glucose monitoring was met favorably by a majority of patients and nurses, according to study findings.

News
August 22, 2024
2 min read
Save

Among adults with diabetes, 57% believe they can manage it with GLP-1s alone

Among adults with diabetes, 57% believe they can manage it with GLP-1s alone

A majority of people with diabetes rely on their primary care provider for diabetes management and believe using drugs such as GLP-1 receptor agonists are enough to manage their disease, according to survey results.

News
August 14, 2024
1 min read
Save

Top in endocrinology: Semaglutide scams; FDA OKs Medtronic’s disposable CGM

Top in endocrinology: Semaglutide scams; FDA OKs Medtronic’s disposable CGM

Researchers purchased prefilled semaglutide pens from six online vendors, of which three were nondelivery scams, according to findings from a research letter published in JAMA Network Open.

News
August 08, 2024
3 min read
Save

Most young people with type 1 diabetes meet HbA1c goal with CGM, remote patient monitoring

Most young people with type 1 diabetes meet HbA1c goal with CGM, remote patient monitoring

Young people with type 1 diabetes enrolled in a digital health program with early initiation of continuous glucose monitoring plus remote patient monitoring had better glycemic outcomes than historical controls, according to study data.

News
August 07, 2024
2 min read
Save

FDA approves next-generation CGM with two-step insertion process

FDA approves next-generation CGM with two-step insertion process

FDA approved Medtronic’s next-generation continuous glucose monitor for people with diabetes, according to an industry press release.

News
July 31, 2024
1 min read
Save

Top in endocrinology: Compounded semaglutide dosing errors; type 1 diabetes immunotherapy

Top in endocrinology: Compounded semaglutide dosing errors; type 1 diabetes immunotherapy

The FDA has received reports of adverse events, including gastrointestinal events, fainting, headache, migraine, dehydration, acute pancreatitis and gallstones, that may be tied to overdosing with compounded semaglutide.

News
July 25, 2024
1 min read
Save

Voluntary medical device correction issued for small subset of FreeStyle Libre 3 sensors

Voluntary medical device correction issued for small subset of FreeStyle Libre 3 sensors

A voluntary medical device correction has been issued for a small number of continuous glucose monitoring sensors distributed in the first half of May, according to an industry press release.

News
July 01, 2024
2 min read
Save

Sustained reduction in HbA1c for adults with type 2 diabetes after starting CGM

Sustained reduction in HbA1c for adults with type 2 diabetes after starting CGM

ORLANDO — Adults with type 2 diabetes experienced a reduction in HbA1c within 3 months of starting continuous glucose monitoring, regardless of insulin therapy, a presenter reported at the American Diabetes Association Scientific Sessions.

News
June 28, 2024
6 min watch
Save

VIDEO: Equal access necessary to realize CGM benefits in pregnancy

VIDEO: Equal access necessary to realize CGM benefits in pregnancy

ORLANDO — In this video exclusive, James R. Gavin III, MD, PhD, Healio | Endocrine Today Co-editor, talks with Camille Powe, MD, about benefits of use of continuous glucose monitoring during pregnancy.

News
June 28, 2024
8 min read
Save

Q&A: CGM ‘revolutionary’ for pregnant women with diabetes

Q&A: CGM ‘revolutionary’ for pregnant women with diabetes

Continuous glucose monitors have the potential to alleviate burdens, improve neonatal outcomes and predict disease progression for pregnant women with type 1, type 2 or gestational diabetes, according to two diabetes experts.

View more